Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Transl Psychiatry ; 4: e478, 2014 Nov 04.
Artigo em Inglês | MEDLINE | ID: mdl-25369145

RESUMO

Fluoxetine is the only psychopharmacological agent approved for depression by the US Food and Drug Administration for children and is commonly used therapeutically in a variety of neurodevelopmental disorders. Therapeutic response shows high individual variability, and severe side effects have been observed. In the current study we set out to identify biomarkers of response to fluoxetine as well as biomarkers that correlate with impulsivity, a measure of reward delay behavior and potential side effect of the drug, in juvenile male rhesus monkeys. The study group was also genotyped for polymorphisms of monoamine oxidase A (MAOA), a gene that has been associated with psychiatric disorders. We used peripheral metabolite profiling of blood and cerebrospinal fluid (CSF) from animals treated daily with fluoxetine or vehicle for one year. Fluoxetine response metabolite profiles and metabolite/reward delay behavior associations were evaluated using multivariate analysis. Our analyses identified a set of plasma and CSF metabolites that distinguish fluoxetine- from vehicle-treated animals and metabolites that correlate with impulsivity. Some metabolites displayed an interaction between fluoxetine and MAOA genotype. The identified metabolite biomarkers belong to pathways that have important functions in central nervous system physiology. Biomarkers of response to fluoxetine in the normally functioning brain of juvenile nonhuman primates may aid in finding predictors of response to treatment in young psychiatric populations and in progress toward the realization of a precision medicine approach in the area of neurodevelopmental disorders.


Assuntos
Desvalorização pelo Atraso/efeitos dos fármacos , Fluoxetina/metabolismo , Comportamento Impulsivo/efeitos dos fármacos , Macaca mulatta/metabolismo , Inibidores Seletivos de Recaptação de Serotonina/metabolismo , Animais , Biomarcadores/metabolismo , Fluoxetina/farmacologia , Individualidade , Masculino , Monoaminoxidase/genética , Inibidores Seletivos de Recaptação de Serotonina/farmacologia
2.
J Am Vet Med Assoc ; 212(6): 857-9, 1998 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-9530428

RESUMO

Eight of 600 Holstein heifers and cows died after ingestion of sweet clover silage (Melilotus sp) that contained excessive concentrations of dicumarol caused by mold infestation. The cattle developed subcutaneous hemorrhages and bled from the vagina, became weak, were unable to move, and died. To the best of our knowledge, this is the first report of sweet clover poisoning in cattle from California and is discussed in light of previous findings in the Midwest and Canada. Sweet clover poisoning is caused by dicumarol, a fungal metabolite produced from substrates in sweet clover, and is a common livestock problem in the Northern Plains and Canada. Sweet clover poisoning should be considered in livestock animals with clinical evidence of hemostatic dysfunction, prolonged coagulation times, subcutaneous hemorrhages, and hemorrhagic abortions. Definite diagnosis of moldy sweet clover poisoning can be accomplished by analysis of serum and feed samples for dicumarol concentrations.


Assuntos
Anticoagulantes/análise , Doenças dos Bovinos/etiologia , Dicumarol/análise , Fabaceae/intoxicação , Intoxicação por Plantas/veterinária , Plantas Medicinais , Silagem/intoxicação , Animais , Anticoagulantes/intoxicação , California , Bovinos , Doenças dos Bovinos/diagnóstico , Doenças dos Bovinos/mortalidade , Dicumarol/intoxicação , Fabaceae/microbiologia , Feminino , Hemorragia/etiologia , Hemorragia/veterinária , Intoxicação por Plantas/complicações , Intoxicação por Plantas/diagnóstico , Silagem/análise , Silagem/microbiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA